Structure and mechanism of action of teicoplanin.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Journal of Hospital Infection

• Publication date

  1986-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0195-6701(86)90011-3PMID 2871101
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and characterization of D-Alanyl-D-Alanine-Agarose

  1985cited by this paper
• Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. IV. Separation and characterization of the components of teichomycin (teicoplanin).

  1984cited by this paper
• Teicoplanin.

  1984cited by this paper
• Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp

  1984cited by this paper
• The structure and mode of action of glycopeptide antibiotics of the vancomycin group.

  1984cited by this paper
• In vitro activity and human pharmacokinetics of teicoplanin

  1984cited by this paper
• The target of penicillin

  1984cited by this paper
• Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. V. Aromatic constituents.

  1984cited by this paper
• Structure elucidation of the teicoplanin antibiotics

  1984cited by this paper
• Anaerobic vaginosis: therapeutic and epidemiological aspects.

  1984cited by this paper
• CALORIMETRIC STUDIES ON THE BINDING OF VANCOMYCIN - LIKE ANTIBIOTICS TO PEPTIDOGLYCAN

  1983cited by this paper
• Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics.

  1983cited by this paper
• The mechanism of the irreversible antimicrobial effects of penicillins: how the beta-lactam antibiotics kill and lyse bacteria.

  1979cited by this paper
• Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties.

  1978cited by this paper
• Specificity of combination between mucopeptide precursors and vancomycin or ristocetin.

  1969cited by this paper

• Engineering non-ribosomal peptide synthesis: tuning the antibiotics engine of the microbial world.

  2026cites this paper
• Natural product inspired antibiotics approved for human use - 1943 to 2025.

  2025cites this paper
• Medicinal applications and environmental fate of antimicrobial peptides: a review

  2025cites this paper
• Evaluation of teicoplanin protein-binding variability and clinical utility of its free serum concentration measurement

  2025cites this paper
• Paradoxical interaction between dalbavancin and β-lactams against endocarditis-associated Enterococcus faecalis clinical isolates.

  2025cites this paper
• Future applications of cyclic antimicrobial peptides in drug delivery

  2025cites this paper
• Surface Functionalization of TiO2 With an Albumin-Teicoplanin Complex to Prevent Implant-Associated Infections.

  2025cites this paper
• Tricalcium phosphate-loaded injectable hydrogel as a promising osteogenic and bactericidal teicoplanin-delivery system for osteomyelitis treatment: An in vitro and in vivo investigation.

  2024cites this paper
• Cyclic peptides: A powerful instrument for advancing biomedical nanotechnologies and drug development.

  2024cites this paper
• Prominent Classes of Antibiotics and their Mechanism of Resistance against Methicillin-Resistant Staphylococcus aureus

  2024cites this paper
• Model‐based dosing optimization and therapeutic drug monitoring practices of teicoplanin in patients with complicated or non‐complicated methicillin‐resistant staphylococcus aureus infection

  2023cites this paper
• Comparative hydrodynamic and nanoscale imaging study on the interactions of teicoplanin-A2 and bovine submaxillary mucin as a model ocular mucin

  2023cites this paper
• Phylogenetic distance and structural diversity directing a reclassification of glycopeptide antibiotics

  2023cites this paper
• Self-association of the glycopeptide antibiotic teicoplanin A2 in aqueous solution studied by molecular hydrodynamics

  2023cites this paper
• Antibiotics and Carbohydrate-Containing Drugs Targeting Bacterial Cell Envelopes: An Overview

  2022cites this paper
• Amyloidogenic Peptides: New Class of Antimicrobial Peptides with the Novel Mechanism of Activity

  2022cites this paper
• Glycopeptide and Lipoglycopeptide Antibiotics

  2022cites this paper
• Molecular Basis of Non-β-Lactam Antibiotics Resistance in Staphylococcus aureus

  2022cites this paper
• Detection of Listeria monocytogenes based on teicoplanin functionalized magnetic beads combined with fluorescence assay

  2021cites this paper
• Immunohistochemical localization and pharmacokinetics of the anti-MRSA drug teicoplanin in rat kidney using a newly developed specific antibody

  2021cites this paper
• Methicillin resistant Staphylococcus aureus - importance of appropriate empirical therapy in serious infections

  2021cites this paper
• Bacterial Targets of Antibiotics in Methicillin-Resistant Staphylococcus aureus

  2021cites this paper
• Combinations of (lipo)glycopeptides with β-lactams against MRSA: susceptibility insights.

  2020cites this paper
• Employment of teicoplanin-coated magnetic particles for quantifying gram-positive bacteria via catalase-catalyzed hydrolysis reaction of H2O2.

  2020cites this paper
• Teicoplanin biosynthesis: unraveling the interplay of structural, regulatory, and resistance genes

  2020cites this paper
• Mycobacterium vaccae Adaptation to Disinfectants and Hand Sanitisers, and Evaluation of Cross-Tolerance with Antimicrobials

  2020cites this paper
• Staphylococcal infections and infertility: mechanisms and management

  2020cites this paper
• Clinical efficacy and safety in patients treated with teicoplanin with a target trough concentration of 20 μg/mL using a regimen of 12 mg/kg for five doses within the initial 3 days

  2020cites this paper
• Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements

  2020cites this paper
• Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches

  2020cites this paper
• Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter

  2020cites this paper
• Population Pharmacokinetics and Pharmacodynamics of Teicoplanin and C‐Reactive Protein in Hospitalized Patients With Gram‐Positive Infections

  2019cites this paper
• Resistance to Glycopeptide Antibiotics

  2019cites this paper
• Antibiotic repurposing: bis-catechol- and mixed ligand (bis-catechol-mono-hydroxamate)-teicoplanin conjugates are active against multidrug resistant Acinetobacter baumannii

  2019cites this paper
• Synergistic microbicidal effect of cationic antimicrobial peptides and teicoplanin against planktonic and biofilm-encased Staphylococcus aureus.

  2019cites this paper
• Mycobacterial Response to Organic Solvents and Possible Implications on Cross-Resistance With Antimicrobial Agents

  2018influential citation
• Teicoplanin – Tigecycline Combination Shows Synergy Against Mycobacterium abscessus

  2018cites this paper
• Estimating the Hospital Burden of Norovirus-Associated Gastroenteritis in England and Its Opportunity Costs for Nonadmitted Patients

  2018cites this paper
• Characterisation of the selective binding of antibiotics vancomycin and teicoplanin by the VanS receptor regulating type A vancomycin resistance in the enterococci

  2017cites this paper
• Targeting a cell wall biosynthesis hot spot.

  2017cites this paper
• Phenotypic Modifications in Staphylococcus aureus Cells Exposed to High Concentrations of Vancomycin and Teicoplanin

  2016cites this paper
• Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profile

  2015cites this paper
• A Review of Teicoplanin Used in the Prevention and Treatment of Serious Infections Caused by Gram-Positive Bacteria and Compared Its Effects with Some other Antibiotics

  2015cites this paper
• Glycopeptide antibiotics: Back to the future

  2014cites this paper
• Derringer desirability and kinetic plot LC-column comparison approach for MS-compatible lipopeptide analysis

  2013cites this paper
• Structure of the complex between teicoplanin and a bacterial cell-wall peptide: use of a carrier-protein approach.

  2013cites this paper
• Teicoplanin-induced leucopenia with immediate resolution after administration of G-CSF

  2012cites this paper
• Investigations into the processes of sorption and desorption of polypeptide antibiotics on Taunit multiwalled carbon nanotubes

  2012cites this paper
• Macrocyclic Antibiotic Selectors in Direct HPLC Enantioseparations

  2012cites this paper
• Cell Wall Targeted Antibiotics

  2010cites this paper
• Study of the sorption of glycopeptide antibiotics on an ultradisperse carbon sorbent

  2010cites this paper
• Unique Aspects of Content Unique Aspects of Software

  2010cites this paper
• Discovery of medically significant lantibiotics.

  2009cites this paper
• Effective Use of Teicoplanin for MRSA Infections in Surgical Patients

  2006cites this paper
• The Evaluation of Serum Total and Free Teicoplanin Concentrations after Intravenous Loading

  2004cites this paper
• Teicoplanin use in a Korean university hospital.

  2003cites this paper
• Teicoplanin-induced neutropenia in a paediatric patient with vertebral osteomyelitis.

  2001cites this paper
• Direct chiral separation of unnatural amino acids by high-performance liquid chromatography on a ristocetin a-bonded stationary phase.

  2001cites this paper
• Teicoplanin-Induced Neutropenia in a Paediatric Patient with Vertebral Osteomyelitis

  2001cites this paper
• Nephrotoxicity of teicoplanin in rats.

  2000cites this paper
• [Glycopeptides].

  2000cites this paper
• MRSAに対するArbekacin, Vancomycin, Teicoplaninのディスク感受性試験結果の信頼性

  1999cites this paper
• In vitro Toxic Effects of Certain Antibiotics on the Fibroblasts of Two Children with I-Cell Disease

  1998cites this paper
• Serum and bone concentrations of teicoplanin and vancomycin: study in an animal model.

  1998cites this paper
• Treatment of Vancomycin‐Resistant Enterococci, with a Focus on Quinupristin‐Dalfopristin

  1996cites this paper
• Teicoplanin or vancomycin in the treatment of Gram–positive infections?

  1995cites this paper
• A critical review of the in-vitro activity of teicoplanin.

  1995cites this paper
• A Risk-Benefit Assessment of Teicoplanin in the Treatment of Infections

  1995cites this paper
• A critkal review of the in-vitro activity of teicoplanin

  1995cites this paper
• Chapter 26 Resistance to glycopeptide antibiotics

  1994cites this paper
• Teicoplaninのin vitroおよびin vivo抗菌力

  1993cites this paper
• Antimicrobial activity and in vitro corneal epithelial toxicity of antimicrobial agents for gram-positive corneal pathogens.

  1993cites this paper
• Synthesis and biological activity of O56-substituted carboxyesters and carboxamides of teicoplanin aglycone.

  1992cites this paper
• Teicoplanin in the treatment of bone and joint infections. Teicoplanin Bone and Joint Cooperative Study Group, USA.

  1992cites this paper
• Teicoplanin in perspective

  1991cites this paper
• Carboxyhydrazides of the aglycone of teicoplanin. Synthesis and antibacterial activity.

  1990cites this paper
• Clinical Pharmacokinetics of Teicoplanin

  1990cites this paper
• Resistance to vancomycin and teicoplanin: an emerging clinical problem

  1990cites this paper
• An unexpected intramolecular cyclization of isothiouronium teicoplanins. II. Reaction mechanism and biological activity.

  1989cites this paper
• Synthesis and biological properties of N63-carboxamides of teicoplanin antibiotics. Structure-activity relationships.

  1989cites this paper
• Leukopenia with Neutropenia Associated with Teicoplanin Therapy

  1989cites this paper
• Structure, biochemistry and mechanism of action of glycopeptide antibiotics

  1989cites this paper
• Teicoplanin metabolism in rats

  1989cites this paper
• Teicoplanin- A New Agent for Gram-Positive Bacterial Infections

  1988cites this paper
• Teicoplanin: A New Glycopeptide Antibiotic Complex

  1988cites this paper
• Microbiological properties of teicoplanin.

  1988cites this paper
• Teicoplanin in infections caused by methicillin-resistant staphylococci.

  1988cites this paper
• Intraventricular administration of teicoplanin in shunt associated ventriculitis caused by methicillin resistant Staphylococcus aureus.

  1988cites this paper
• Therapeutic Update on Glycopeptide and Lipopeptide Antibiotics

  1988cites this paper
• Open study of teicoplanin in gram-positive infections.

  1988cites this paper
• Synthesis and biological activity of some esters of the N-acetylglucosaminyl aglycone and of the aglycone of teicoplanin.

  1987cites this paper
• Effects of the new glycopeptide antibiotic teicoplanin on platelet function and blood coagulation

  1987cites this paper
• Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients

  1987cites this paper